Ernexa Therapeutics, Inc. (ERNA)
1.85
+0.02
(+1.09%)
USD |
NASDAQ |
Nov 06, 16:00
1.85
0.00 (0.00%)
After-Hours: 16:56
Ernexa Therapeutics Research and Development Expense (Annual) : 4.156M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.156M |
| December 31, 2024 | 4.604M |
| December 31, 2023 | 5.92M |
| December 31, 2022 | 10.39M |
| December 31, 2021 | 12.70M |
| December 31, 2020 | 3.951M |
| December 31, 2019 | 0.026M |
| December 31, 2018 | 0.072M |
| December 31, 2017 | 0.139M |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | 0.144M |
| December 31, 2010 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2009 | |
| December 31, 2008 | |
| December 31, 2007 | 0.145M |
| December 31, 2006 | 0.207M |
| December 31, 2005 | 0.248M |
| December 31, 2004 | 0.329M |
| December 31, 2003 | 0.329M |
| December 31, 2002 | 0.012M |
| December 31, 2001 | 0.101M |
| December 31, 2000 | 0.43M |
| December 31, 1999 | 0.842M |
| December 31, 1998 | 0.714M |
| December 31, 1997 | 1.60M |
| December 31, 1996 | 3.396M |
| December 31, 1995 | 1.471M |
| December 31, 1994 | 1.972M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cerenome, Inc. | 8.379M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |
| Savara, Inc. | 81.40M |